Tallinn-based medtech startup Lifeyear raises €1.3M

Estonian medical technology startup Lifeyear has raised €1.3M from venture funds Verge HealthTech Fund, Tilia Impact Ventures, PurposeTech and Estonian business angels. The company received another €1.5M in technology development grants from the Estonian government. Lifeyear will use the raised funds to launch its digital platform for cardiac care in selected UK hospitals.

Lifeyear is a healthcare technology company that focuses on collecting information about cardiovascular performance. The company was founded in 2021 and is headquartered in Tallinn, Estonia. Lifeyear was founded by a British-Estonian team: British cardiologist Eleanor Weeks, trained by the UK National Health Service, and Estonians Siim Saare (CEO) and Timo Mitt (CTO).

Verge HealthTech Fund is a venture capital fund that invests in early-stage medical technology startups. The company was founded in 2018 in Singapore. The fund's founders are Dr. Joseph Mocanu and Ed Deng.

Tilia Impact Ventures is a venture capital firm specializing in investing in social enterprises. Founded in 2018, it is based in Prague, Czech Republic. The founders are Silke Horáková and Petr Vítek.

PurposeTech is a venture capital company founded in 2022 and headquartered in Prague, Czech Republic. The purpose of the fund is to support technology startups that are focused on creating a positive social impact. The company mainly works in the field of technology startups. The founder of PurposeTech is Zdenek Fred Fous.